Diet, apoptosis, and carcinogenesis

Advances in Experimental Medicine and Biology

Volumn 422, Issue , 1997, Pages 97-107

  Albright, Craig D ^a   Liu, Rong ^a   Mar, Mai Heng ^a   Shin, Ok Ho ^a   Vrablic, Angelica S ^a   Salganik, Rudolf I ^a   Zeisel, Steven H ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE;

APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; DISEASE ASSOCIATION; GROWTH REGULATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VITAMIN DEFICIENCY;

ANIMALIA; MUS MUSCULUS;

EID: 0030701923     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-2670-1_8     Document Type: Article

References (54)

1. Ghoshal, A.K. and Farber, E. (1984). The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 5, 1367-1370.
2. Chandar, N. and Lombardi, B. (1988). Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and choline- supplemented diet. Carcinogenesis 9, 259-263.
3. Rogers, A.E. (1995). Methyl donors in the diet and responses to chemical carcinogens. Am J Clin Nutrition 61, 659S-665S.
4. Yokoyama, S., Sells, M.A., Reddy, T.V. and Lombardi, B. (1985). Hepatocarcinogenic and promoting action of a choline-devoid diet in the rat. Cancer Res 45, 2834-2842.
5. Abonabi, S.E., Lombardi, B. and Shinozuka, H. (1982). Possible mechanism(s) of action of a choline devoid diet and phenobarbital as promoters of carcinogenesis. Cancer Res 42, 412-415.
6. Ghoshal, A.K., Ahluwalia, M. and Farber, E. (1983). The rapid induction of liver cell death in rats fed choline-deficient methionine low diet. Am J Pathol 113, 309-314.
7. Albright, C.D., Liu, R., Bethea, T.C., da Costa, K.-A., Salganik, R.I. and Zeisel, S.H. (1996). Choline deficiency induces apoptosis in SV40-immortalized CWSV-1 rat hepatocytes in culture. FASEB J 10, 510-516.
8. Shin, Ok-Ho, Mar, M.-H., Albright, C.D., Citarella, M.T., da Costa, K.-A. and Zeisel, S.H. (1996). Methylgroup donors cannot prevent apoptotic death of rat hepatocytes induced by choline deficiency. J Cell Biochem (in press).
9. Zeisel, S.H., da Costa, K.-A., Albright, C.D. and Shin, O.-K. (1995). Choline and hepatocarcinogenesis in the rat. Adv Exp Biol Med 375, 65-74.
10. Shigenaga, M.K. and Ames, B.N. (1993). Oxidants and mitogenesis as causes of mutation and cancer: the influence of diet. Basic Life Sciences 61, 419-436.
11. Snyderwine, E.G. (1994). Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer 74 (3 Suppl). 1070-1077.
12. Webster, R.P., Gawde, M.D. and Bhattacharya, R.K. (1996). Modulation of carcinogen- induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Lett. 98, 129-135.
13. Khan, N., Yang, K., Newmark, H., Wong, G., Telang, N., Rivlin, R. and Lipkin, M. (1994). Mammary ductal epithelial cell hyperproliferation and hyperplasia induced by a nutritional stress diet containing four components of a western-style diet. Carcinogenesis 15, 2645-2648.
14. Appel, M.J. and Woutersen, R.A. (1994). Modulation of growth and cell turnover of preneoplastic lesions and of prostaglandin levels in rat pancreas by dietary fish oil. Carcinogenesis 15, 2107-2112.
15. Birt, D.E., Pelling, J.C., Anderson, J. and Barnett, T. (1994). Consumption of reduced- energy, low-fat diet or constant-energy high-fat diet during mezerin treatment inhibited mouse skin tumor promotion. Carcinogenesis 15, 341-2345.
16. Rao, C.V., Simi, B., Wynn, T.T., Garr, K. and Reddy, B.S. (1996). Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res 56, 532-537.
17. Black, H.S., Okotie-Eboh, G., Gerguis, J., Urban, J.I. and Thornby, J.I. (1995). Dietary fat modulates immunoresponsiveness in UV-irradiated mice. Photochem Photobiol 62, 964-969.
18. Payne, C.M., Bernstein, H., Bernstein, C. and Garewal, H. (1995). Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruclural Biol 19, 221-248.
19. La Porta, C.A. and Comolli, R. (1995). Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis. Carcinogenesis 16, 1233-1238.
20. da Costa, K.-A., Cochary, E.F., Blusztajn, J.K., Garner, S.C. and Zeisel, S.H. (1993). Accumulation of 1.2-sn-diradylglycerol with increased nuclear membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline deficient rats. J Biol Chem 268, 2100-2105.
21. da Costa, K.-A., Garner, S.C., Chang, J. and Zeisel, S.H. (1995). Effects of prolonged (1 year) choline deficiency and subsequent refeeding of choline on 1,2-sn-diradylglycerol, fatty acids and protein kinase C in rat liver. Carcinogenesis 16, 327-334.
22. Enwonwu, C.O and Meeks, V.I. (1995). Bionutrition and oral cancer in humans. Critical Rev Oral Biol 6, 5-17.
23. Anderson, M.T., Staal, F.J.T., Gitler, C., Herzenberg, L.A. and Herzenberg, L.A. (1994). Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA 91, 11527-11531.
24. Zeisel, S.H. (1981). Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1, 95-121.
25. Zeisel, S.H. (1993). Choline phospholipids: signal transduction and carcinogenesis. FASED J 7, 551-557.
26. Ghoslial, A.K. and Farber, H. (1993). Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective. Lab Investigation 68, 255-260.
27. Cohmbano, A. (1995). Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58, 181-190.
28. Wyllie, A.M. (1987). Cell death, Int J Cytol 17 (Suppl). 755-785.
29. Woodworth, C.D., Secott, T. and Isom, U.C. (1986). Transformation of rat hepatocytes by transfection with simian virus 40 DNA to yield proliferating differentiated cells. Cancer Res 46, 4018-1026.
30. Woodworth, C.D., Kneder, J.W., Mengel, L., Miller, T., Meng, Y. and Isom, H.C. (1988). Tumorigenicity ot simian virus 40-hepatocyte cell lines: ettect ot in vitro and in vivo passage on expression of liver-specific genes and oncogenes. Molec Cell Biol 8, 4492-4501.
31. Arends, M.J., Mcuregor, A.M., Toft, N.J., Brown, H.J.H. and Wyllie, A.M. (1993). Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68, 1127-1133.
32. Albright, C.D., Salganik, R.I., Kaufmann, W.K. and Zeisel, S.H. (1996). Apoptosis is induced independent of p53 by choline deficiency m SV40-immortalized hepatocytes and a human liepatoma cell line. (Suhmitted).
33. Zeisel, S.U. and Blusztajn, J.K. (1994). Choline and human nutrition. Annu Rev Nutr 14, 269-296.
34. Kim, V.-L., Miller, S.W., da Costa K.-A., Nadeau, M., Smith, D., Selhub, J., Zeisel, S.U. and Mason, J.B. (1995). Folate deficiency causes secondary depletion of choline and phosphocholine in liver. J Nutr 124, 2197-2203.
35. Meikrantz, W. and Schlegel, R. (1995). Apoptosis and the cell cycle. J Cell Biochem 58, 160-174.
36. Sen, S. and D'Incalci, M. (1992). Apoptosis: biochemical events and relevance to cancer chemotherapy. FEBS Lett 307, 122-127.
37. Symonds, M., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T. and Van Dyke, T. (1994). p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711.
38. Harper, J.M., Adami, G.R., Wei, N., Keyomarsi, K., Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
39. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
40. EI-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Peitenpol, J.A., Burrell, M., Mill, D.H., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W. and Vogelstein, B. (1994). WAFI/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54, 1169-1174.
41. Zeisel, S.U., Albright, C.D., Mar, M.-M., Salganik, R.I., Shin, Ok-Ho and da Costa, K.- A. (1996). Cholinc deficiency selects for resistance to apoptosis and causes tumorigenic transformation of rat hepatocyles. (Submitted).
42. Albright, C.D., Jones, R.T., Hudson, L.A., Fontana, J.A. and Resau, J.M. (1990). Intercellular communication in bronchial epithelial cells: review of evidence for a possible role in lung carcmogenesis. Toxicol Pathol 6, 379-398.
43. Boudreau, N., Sympson, C.J., Werb, Z. and Bissell, M.J. (1995). Suppression of ICT: and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.
44. Shinozuka, M., Masuhara, M., Kubo, Y. and Katyal. S.L. (1993). Growth factor and receptor modulations in rat liver by choline-methionine deficiency. J Nutr Biochem 4, 610-617.
45. Luetteke, N.C., Michalopoulos, G.K., Teixido, J., Gilmore, R., Massagué, J. and Lee, D.C. (1988). Characterization of high molecular weight transforming growth factor a produced by rat hepatocellular carcinoma cells. Biochemistry 27, 6487-6494.
46. Paniella, A. and Massagué. J. (1991). Multiple signals activate cleavage ol the membrane transforming growth factor-α precursor. J Biol Chem 266, 5769-5773.
47. Bursch, W., Oberhammer, K. Jirtle, R.L., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A.F. and Schulte-Hermann, R. (1993). Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br J Cancer. 531-536.
48. Santoni-Rugiu, Nagy, P., Jensen, M.R., Factor, V.M. and Thorgeirsson, S.S. (1996). Evolution of neoplaslic development in the liver of transgenic mice co-expressing c-mye and transforming growth factor-β. Am J Pathol 149, 407-428.
49. Hohmoto, M., Kato, J., Takimolo, R., Terui, T., Mogi, Y. and Niitsu, Y. (1995). Identification of a transforming growth factor beta-1 activator derived from a human gastric cancer cell line. Br J Cancer 72, 676-682.
50. McMahon, G.A., Digram, J.D. and Gentry, L.E. (1996). Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated pcptidc. Biochem J 313, 343-351.
51. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schultz, P., Heldin, C.H. and Miyazono, K. (1993). Cloning of TGFB type I receptor that forms a heteromeric complex with the TGFB type II receptor, Cell 75, 681-692.
52. Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P. and Massagué. J. (1994). Cloning of p27Kip1, a cyclin-dependent kinasc inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
53. Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880.
54. Oberhammer, F., Wilson, J.W., Dive, C., Morris, I.D., Hickman. J.A., Wakcling, A.E., Walker, PR. and Sikorska, M. (1993). Apoptolic death in epithelial cells: cleavage of DNA to 300 and or 50 kh fragments prior to or in the absence of intcmuclcosomal fragmentation. EMBO.I 12. 3679-3684.